Nishikawa, T.; Matsui, M.; Onishi, S.; Ushiro, K.; Asai, A.; Kim, S.-K.; Nishikawa, H.
Long-Term Outcomes after Switching to Tenofovir Alafenamide in Patients with Chronic Hepatitis B. Int. J. Mol. Sci. 2024, 25, 2245.
https://doi.org/10.3390/ijms25042245
AMA Style
Nishikawa T, Matsui M, Onishi S, Ushiro K, Asai A, Kim S-K, Nishikawa H.
Long-Term Outcomes after Switching to Tenofovir Alafenamide in Patients with Chronic Hepatitis B. International Journal of Molecular Sciences. 2024; 25(4):2245.
https://doi.org/10.3390/ijms25042245
Chicago/Turabian Style
Nishikawa, Tomohiro, Masahiro Matsui, Saori Onishi, Kosuke Ushiro, Akira Asai, Soo-Ki Kim, and Hiroki Nishikawa.
2024. "Long-Term Outcomes after Switching to Tenofovir Alafenamide in Patients with Chronic Hepatitis B" International Journal of Molecular Sciences 25, no. 4: 2245.
https://doi.org/10.3390/ijms25042245
APA Style
Nishikawa, T., Matsui, M., Onishi, S., Ushiro, K., Asai, A., Kim, S.-K., & Nishikawa, H.
(2024). Long-Term Outcomes after Switching to Tenofovir Alafenamide in Patients with Chronic Hepatitis B. International Journal of Molecular Sciences, 25(4), 2245.
https://doi.org/10.3390/ijms25042245